Application and Efficiency of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange in Laryngeal Microsurgery.

The Laryngoscope 2022 Vol.132(5) p. 1061-1068

Huh G, Min S, Cho SD, Cho YJ, Kwon SK

관련 도메인

Abstract

[OBJECTIVES/HYPOTHESIS] This study aimed to analyze the feasibility of transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during laryngeal microsurgery (LMS) and investigated its efficiency and application according to the location of the lesion.

[STUDY DESIGN] Retrospective chart review.

[METHODS] Patients over 20 years of age who underwent LMS without underlying cardiac, pulmonary, or cerebrovascular disease were retrospectively reviewed. Overall, 54 patients with endotracheal intubation (ETI) and 44 patients with THRIVE were included. The operation and anesthesia time, induction and emergence time, oxygen saturation (SpO ), and transcutaneous carbon dioxide (TcCO ) levels were analyzed and compared between the two ventilation methods according to disease subsite.

[RESULTS] Compared with ETI, patients with THRIVE presented reduced operation time (16.3 ± 9.69 min vs. 21.9 ± 12.0 min), anesthesia time (33.6 ± 11.4 min vs. 45.4 ± 13.9 min), emergence time (6.73 ± 2.49 min vs. 8.52 ± 3.17 min), without significant decreases in SpO but with increased TcCO (10.9 ± 6.12% vs. 7.33 ± 3.86%). Comparing THRIVE to ETI for lesions at the glottis yielded similar findings, which were particularly more significant. However, lesions above the glottis presented no significant difference for any parameters between THRIVE and ETI groups. Lesions involving multiple subsites and prolonged operation time were risk factors for the intraoperative conversion of ventilation method.

[CONCLUSION] THRIVE is reliable for maintaining oxygenation during LMS and is efficient in reducing the operation and emergence times, leading to shorter anesthesia time, especially for lesions at the glottis. However, caution is required administering THRIVE, when lesion involves multiple subsites, and when operation time is prolonged.

[LEVEL OF EVIDENCE] 3 Laryngoscope, 132:1061-1068, 2022.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 2
해부 cardiac scispacy 1
해부 pulmonary scispacy 1
합병증 laryngeal microsurgery scispacy 1
합병증 cerebrovascular disease scispacy 1
합병증 lesions scispacy 1
약물 oxygen C0030054
oxygen
scispacy 1
약물 carbon dioxide C0007012
carbon dioxide
scispacy 1
약물 TcCO → transcutaneous carbon dioxide scispacy 1
약물 [OBJECTIVES/HYPOTHESIS scispacy 1
약물 7.33 scispacy 1
질환 LMS → laryngeal microsurgery scispacy 1
질환 cerebrovascular disease C0007820
Cerebrovascular Disorders
scispacy 1
질환 glottis C0017681
glottis
scispacy 1
질환 Laryngeal Microsurgery scispacy 1
질환 disease scispacy 1
질환 lesions scispacy 1
기타 Patients scispacy 1

MeSH Terms

Adult; Apnea; Humans; Insufflation; Intubation, Intratracheal; Microsurgery; Retrospective Studies

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문